🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Approximately 40% of colorectal cancer patients will develop colorectal liv...
Status
Unknown
Location
Severance Hospital, Yonsei University Health System
Start Date
2021-11-01
Trial ID
NCT05103020
This is a multi-center, open-label, randomized, phase 2, two-arm clinical t...
Status
Completed
Location
Multiple Locations
Start Date
2006-11-01
Trial ID
NCT00418938
Treatments Being Tested
The primary objective of the study is to determine the maximum tolerated do...
Status
Completed
Location
Alabama Oncology
Start Date
2013-03-29
Trial ID
NCT01803282
TTX-080-001 is a Phase 1, open label, dose escalation and dose expansion cl...
Status
Recruiting
Location
Arizona Oncology Associates
Start Date
2020-07-14
Trial ID
NCT04485013
This is a Phase 1 dose-escalation study with three dose levels to determine...
Status
Completed
Location
New York Presbyterian Hospital/ Weill Cornell Medical College
Start Date
2010-12
Trial ID
NCT01274624
Treatments Being Tested
PURPOSE: This randomized phase III trial is studying cetuximab and/or bevac...
Status
Completed
Location
Providence Cancer Center at Providence Hospital
Start Date
2005-11
Trial ID
NCT00265850
Treatments Being Tested
This clinical program aims to evaluate the activity and efficacy of cetuxim...
Status
Active Not Recruiting
Location
A.O.U. Ospedali Riuniti
Start Date
2021-07-15
Trial ID
NCT05312398
Treatments Being Tested
The study is designed to analyze the pathological tumor response on resecte...
Status
Completed
Location
Clinique Saint Luc
Start Date
2013-05
Trial ID
NCT01858649
Treatments Being Tested
The purpose of this study is to evaluate the safety and preliminary clinica...
Status
Terminated
Location
Sarah Cannon Research Institute at Health One
Start Date
2024-10-08
Trial ID
NCT06509906
This phase III trial compares hepatic arterial infusion (HAI) (pump chemoth...
Status
Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2023-10-19
Trial ID
NCT05863195